Susquehanna International Group, LLP Regeneron Pharmaceuticals, Inc. Transaction History

Susquehanna International Group, LLP

$568 Billion
Q1 2025

A detailed history of Susquehanna International Group, LLP transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 151,458 shares of REGN stock, worth $84.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

151,458

Previous 82,192 84.27%

Holding current value

$84.3 Million

Previous $58.5 Million 64.07%

% of portfolio

0.02%

Previous 0.01%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$634.14 - $744.83 $43.9 Million - $51.6 Million	69,266 Added 84.27%	151,458 $96.1 Million
Q4 2024 Feb 14, 2025	BUY	$701.85 - $1046.91 $34.2 Million - $51 Million	48,682 Added 145.28%	82,192 $58.5 Million
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $3.17 Million - $3.72 Million	3,098 Added 10.19%	33,510 $35.2 Million
Q2 2024 Aug 15, 2024	SELL	$883.2 - $1071.19 $5.79 Million - $7.03 Million	-6,561 Reduced 17.75%	30,412 $32 Million
Q1 2024 May 07, 2024	SELL	$902.69 - $993.35 $48 Million - $52.9 Million	-53,224 Reduced 59.01%	36,973 $35.6 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $27.4 Million - $31.2 Million	35,337 Added 64.41%	90,197 $79.2 Million
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $13.3 Million - $16.2 Million	-19,157 Reduced 25.88%	54,860 $45.1 Million
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $15.5 Million - $18.4 Million	-22,187 Reduced 23.06%	74,017 $53.2 Million
Q1 2023 May 16, 2023	BUY	$680.49 - $826.97 $10.7 Million - $13 Million	15,707 Added 19.51%	96,204 $79 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $40.5 Million - $44 Million	57,355 Added 247.84%	80,497 $58.1 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $14.7 Million - $18.5 Million	-25,609 Reduced 52.53%	23,142 $15.9 Million
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $6.89 Million - $9.28 Million	-12,561 Reduced 20.49%	48,751 $28.8 Million
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $68.3 Million - $80.1 Million	-114,711 Reduced 65.17%	61,312 $42.8 Million
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $51.2 Million - $63.2 Million	-94,140 Reduced 34.85%	176,023 $111 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $50.6 Million - $60 Million	-88,164 Reduced 24.6%	270,163 $163 Million
Q2 2021 Aug 11, 2021	BUY	$472.8 - $558.54 $68.2 Million - $80.5 Million	144,175 Added 67.32%	358,327 $200 Million
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $223 Million - $273 Million	-498,689 Reduced 69.96%	214,152 $101 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $248 Million - $315 Million	518,331 Added 266.48%	712,841 $344 Million
Q3 2020 Nov 16, 2020	BUY	$544.75 - $658.21 $49.1 Million - $59.4 Million	90,210 Added 86.49%	194,510 $109 Million
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $34.1 Million - $44.5 Million	69,067 Added 196.03%	104,300 $65 Million
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $9.66 Million - $14.2 Million	-28,736 Reduced 44.92%	35,233 $17.2 Million
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $54.4 Million - $74.7 Million	-198,283 Reduced 75.61%	63,969 $24 Million
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $20.7 Million - $24.1 Million	75,791 Added 40.65%	262,252 $72.7 Million
Q2 2019 Aug 16, 2019	BUY	$299.6 - $414.82 $17.8 Million - $24.7 Million	59,560 Added 46.93%	186,461 $58.4 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $37 Million - $51.3 Million	123,590 Added 3732.71%	126,901 $39.7 Million
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $914,944 - $1.08 Million	2,459 Added 288.62%	3,311 $1.36 Million
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $1.51 Million - $1.82 Million	-4,505 Reduced 84.1%	852 $318,000
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $57.7 Million - $67.1 Million	-164,234 Reduced 96.84%	5,357 $2.16 Million
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $39.2 Million - $47.5 Million	137,780 Added 433.12%	169,591 $58.5 Million
Q1 2018 May 15, 2018	BUY	$315.82 - $393.78 $5.23 Million - $6.52 Million	16,564 Added 108.64%	31,811 $11 Million
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $4.11 Million - $5.38 Million	11,447 Added 301.24%	15,247 $5.73 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $1.64 Million - $1.92 Million	3,800	3,800 $1.7 Million

Others Institutions Holding REGN

# of Institutions

1,396

Shares Held

87.6M

Call Options Held

1.38M

Put Options Held

1.37M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $59.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Regeneron Pharmaceuticals, Inc. Transaction History